You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
7 May 2024
Q1 statement / Q1 financial report 2024
29 April 2024
Jahresfinanzbericht 2023
Annual financial report 2023
25 April 2024
Analystenkonferenz zum Finanzjahr 2023 – März 2024
28 March 2024
Geschäftsbericht 2023
Full Year Results 2023 – March 2024
6 November 2023
Q3 statement / Q3 financial report 2023
2 November 2023
Quartalsergebnisse Q1-Q3 – November 2023
Quarterly Results Q1-Q3 – November 2023
10 August 2023
Half-yearly financial report 2023
9 May 2023
Q1 statement / Q1 financial report 2023
23 March 2023
Full Year Results 2022– March 2023
Geschäftsbericht 2022 (ESEF)
Annual financial report 2022
Geschäftsbericht 2022
Vergütungsbericht 2022
Remunerations Report 2022
Analystenkonferenz zum Finanzjahr 2022 – März 2023
14 November 2022
Q3 statement / Q3 financial report 2022
Quarterly Results Q1-Q3 – November 2022
Qartalsergebnisse Q1-Q3 – November 2022
11 August 2022
Präsentation zum Halbjahr 2022 – August 2022
Half-yearly financial report 2022
Half Year Results 2022 – August 2022
1 July 2024
Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion
24 June 2024
Biotest’s sustainability campaign GoFuture part of the new documentary ‘Future Seeds’
17 June 2024
Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo
Biotest AG: Annual General Meeting approves dividend distribution
Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024
19 April 2024
Biotest AG opens 12th plasma collection centre in Germany
30
Jul 24
Publication half-yearly financial report
05
Nov 24
Publication quarterly statement (call-date Q3)
